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Background: Endogenous fungal endophthalmitis is a serious vision-threatening condition that occurs in
immunosuppressed patients with candidemia.
Findings: We report a complicated case of Candida albicans chorioretinitis that progressed to endophthalmitis. The
patient required intravitreal and systemic anti-fungal medications with pars plana vitrectomy for successful treatment.
Multimodal imaging using fundus photography, fluorescein angiography, spectral domain optical coherence
tomography, and fundus autofluorescence was obtained throughout treatment. These modalities localized the Candida
infection in the choroid, penetrating Bruch’s membrane, the retinal pigment epithelium, and the retina to enter the
vitreous cavity. This infectious route resulted in loss of the retinal pigment epithelium, photoreceptors, and outer retinal
layers, with scar formation that resulted in vision loss and increased future risk of choroidal neovascular membranes.
Conclusions: Multimodal imaging of C. albicans chorioretinitis allows for accurate diagnosis, assessment of response to
therapy, and prognosis for visual recovery and future complications.
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autofluorescence; Fluorescein angiographyFindings
Introduction
Endogenous fungal endophthalmitis is a serious vision-
threatening condition. In the United States, yeasts are the
most common causative organism, accounting for 75 % of
cases [1]. Among yeasts, Candida albicans is the most
common pathogen [1]. In 14 % of patients with Candide-
mia, ocular complications occur [2]. The majority of these
patients develop chorioretinitis with 1.6 % of patients
advancing to endophthalmitis [2]. In patients with yeast
endophthalmitis, visual acuity outcomes can be poor with
only 56 % of eyes achieving vision of 20/200 or better [1].
This case report describes the clinical course of a patient
with C. albicans chorioretinitis that progressed to recal-
citrant endophthalmitis. Using multimodal imaging, we
chronicle the features of chorioretinitis through multiple
medical and surgical therapies.* Correspondence: mititelu@wisc.edu
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A 48-year-old male presented with blurred central vision
in his right eye. Past ocular history included bilateral
pseudophakia. Medical history was significant for a 4-year
history of rheumatoid arthritis on oral prednisone 15 mg
daily and a recent history of nephrolithiasis. One month
prior to presentation, his nephrolithiasis was treated with
extracorporeal shock wave lithotripsy and ureteral stent
placement. One week after lithotripsy, urine cultures grew
C. albicans and the patient started oral fluconazole
300 mg daily. For 3 weeks, the patient complained of
blurred central vision in the right eye without redness or
floaters.
On examination, visual acuity was 20/100 OD and 20/
20 OS. Pupils, intraocular pressures, and visual fields
were normal. The anterior segment showed bilateral
pseudophakia with no inflammation. Posterior segment
exam demonstrated clear media without vitritis and a
white, elevated foveal infiltrate (half disk diameter) with
indiscrete borders (Fig. 1a). Fluorescein angiography (FA)
displayed an early hyperfluorescent lesion with late stainingis article is distributed under the terms of the Creative Commons
reativecommons.org/licenses/by/4.0), which permits unrestricted use,
m, provided you give appropriate credit to the original author(s) and the
ons license, and indicate if changes were made. The Creative Commons
ativecommons.org/publicdomain/zero/1.0/) applies to the data made
ed.
Fig. 1 Initial appearance of the chorioretinitis. Color fundus photograph (a) showing the white, elevated, and fluffy chorioretinal lesion. Early (b)
and late (c) phases of the FA demonstrating early hyperfluorescence and late staining. Color fundus photography 2 weeks later displaying
significant vitritis that obscures retinal detail (d)
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Candida chorioretinitis was made and his fluconazole was
increased to 600 mg/day. The following day, the ureteral
stent was removed without catheterization and blood cul-
tures grew C. albicans. Although an infectious disease con-
sult was requested on the day of presentation, the patient
was seen 1 week later, and the fluconazole dose was in-
creased to 800 mg daily.
The patient was lost to follow-up and presented 2 weeks
later with new floaters OD. On examination, visual acuity
remained 20/100 OD, the anterior segment was un-
changed, and the posterior segment displayed vitritis with
a fluffy chorioretinal lesion (Fig. 1d). Candida endophthal-
mitis was diagnosed, the patient received a same-day
intravitreal injection of amphotericin B (5 μg/0.1 mL) and
was placed on intravenous amphotericin B (0.1 mg/mL).
The patient developed acute kidney injury (AKI) 1 week
after initiation of treatment, requiring discontinuation of
amphotericin B and resumption of fluconazole. At this
time, blood cultures were negative for C. albicans.
One week after intravitreal amphotericin B, there was
improvement in the fluffy appearance of the macular
lesion. Spectral domain optical coherence tomography
(SD-OCT) demonstrated an elevated, hyperreflective fo-
veal lesion at the vitreoretinal inferface that appeared tobe emanating from the retinal pigment epithelium
(RPE), with obscuration of the retinal layers (Fig. 2a).
The patient received three intravitreal voriconazole
injections (100 μg/0.1 mL) and was placed on sys-
temic voriconazole (200 mg twice daily) therapy. After
2 months, the lesion flattened and developed well-
demarcated borders but vitritis persisted. SD-OCT
displayed an improving but still elevated hyperreflec-
tive lesion now localized at the nerve fiber layer with per-
sistent focal discontinuity of the RPE (Fig. 2b). At its
borders, the inner retinal architecture showed improved
definition, but the outer retinal layers displayed atrophy
with increased transmission defect. Due to the persistent
vitreous infiltrates, the patient underwent pars plana vitrec-
tomy (PPV). The postsurgical SD-OCT showed continued
regression of the elevated, hyperreflective lesion (Fig. 2c).
The borders demonstrated preserved inner retinal layers
with atrophy of the outer retina and choroidal hyperreflec-
tivity from transmission defect. The patient continued
systemic voriconazole for an additional month without fur-
ther intravitreal therapy.
Final multimodal imaging displayed a foveal scar
(Fig. 3a). On fundus autofluorescence (FAF), the scar is
hypofluorescent consistent with RPE loss (Fig. 3b). On SD-
OCT, the outer retina is atrophic, the RPE layer is absent, a
Fig. 2 Regression of the chorioretinal lesion. SD-OCT imaging performed 1 week after intravitreal amphotericin B treatment (a), 2 months after three
intravitreal voriconazole injections (b), and after PPV (c). The inner retinal hyperreflective lesion regresses with time. At its borders, the RPE is elevated
and discontinuous with loss of outer plexiform, outer nuclear, external limiting membrane, IS/OS, and RPE. Inner retinal tissues are preserved and
subretinal scar is present
Lavine and Mititelu Journal of Ophthalmic Inflammation and Infection  (2015) 5:24 Page 3 of 5subretinal scar underlies the inner retinal layers, and a
postinflammatory epiretinal membrane (ERM) co-exists
(Fig. 3c). The photoreceptor loss and RPE atrophy primar-
ily caused a final visual acuity of 20/100 OD.Discussion
We present a complicated case of C. albicans chorioretini-
tis that progressed to endogenous endophthalmitis, requir-
ing multiple local and systemic antifungal medications and
Fig. 3 Final appearance of the chorioretinal lesion. Color fundus
photography (a), FAF (b), and SD-OCT (c) were performed 2 months
after PPV. A subfoveal scar is present (a) with destruction of outer
plexiform, outer nuclear, external limiting membrane, IS/OS, and RPE
(c). The inner retinal layers, however, are preserved (c). The FAF shows
loss of autofluorsescence corresponding to RPE destruction (b)
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clude hospitalization, surgery, cancer, diabetes, intravenous
drug use, and indwelling catheters [1]. Risk factors for this
particular case include recent lithotripsy of renal calculi
and immunosuppression from prednisone therapy [3]. It is
common for lithotripsy to cause asymptomatic Candiduria;
in this immunocompromised patient, the Candiduria likely
caused Candidemia, leading to chorioretinitis. In a pro-
spective, multicenter study of 11 patients with chorioretini-
tis, none progressed to endophthalmitis [4]. Although
limited by a small number of patients, this study suggests
that our patient had been initially underdosed with flucon-
azole 300 mg daily. Once Candida endophthalmitis devel-
oped, our patient received both intravitreal and systemic
amphotericin B. However, therapy was changed to oral and
intravitreal voriconazole after AKI from amphotericin B.
Voriconazole is effective against fluconazole-resistant C.
albicans strains and has excellent ocular penetration [5]. It
has been shown that Candida species preferentially infect
the vitreous and form loculated microabscesses, which
may ultimately require vitrectomy for clearance [6]. In the
case of our patient, despite stabilization of the infection
with aggressive systemic and intravitreal antifungal man-
agement, PPV was required to decrease the fungal load.
To our knowledge, this is the first report using FA, SD-
OCT, and FAF to follow a case of Candida chorioretinitis
progressing to endophthalmitis. Our patient initially pre-
sented with a white, elevated chorioretinal lesion (Fig. 1a).
FA displayed a foveal lesion with early hyperfluorescence
and late staining (Fig. 1b, c), consistent with prior reports
of Candida chorioretinitis [7]. The lack of late leakage rules
out choroidal neovascularization (CNV). However, the
presence of vascular leakage near the lesion does not ex-
clude Candida chorioretinitis as the cause of the macular
lesion, as this angiogram pattern has been documented [8].
SD-OCT and FAF imaging help the clinician determine
the route of infectious seeding, the etiology and treatment
options, and the prognosis for visual recovery. SD-OCT
findings early in the course of treatment demonstrated an
elevated, hyperreflective lesion at the retina-vitreous inter-
face with poorly defined borders and obscured underlying
retinal detail (Fig. 2a). At the edge of the lesion, elevation
of the RPE suggests that the lesion originated in the
choroid. We suspect that this lesion is a focus of inflam-
matory and infectious material that locally infiltrated the
macula. As the lesion was treated, the inner retinal hyper-
reflective lesion regressed but the borders demonstrated a
persistently elevated, discontinuous RPE (Fig. 2b, c). These
characteristics suggest that the Candida infection pro-
gressed via choroidal infiltration through Bruch’s mem-
brane and RPE, into the retina and the vitreous. We
hypothesize that this seeding is secondary to spread
through the short posterior ciliary artery rather than
through the central retinal artery [9,10] because of the
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of an explosive endophthalmitis. Cho et al. previously
evaluated Candida chorioretinitis with SD-OCT, demon-
strating RPE elevation and outer retinal destruction in
early, active lesions and inner retinal hyperreflective eleva-
tion with blockage in late, inactive lesions [11]. Our lesion
showed SD-OCT characteristics of both early, active and
late, inactive chorioretinitis stages as it evolved during the
clinical course. We hypothesize that clinically and through
multimodal imaging, our lesion demonstrated active fea-
tures, especially given its pronounced hyperfluorescence
on FA and its regression with treatment.
Vision loss in our patient occurred primarily due to
photoreceptor loss and scarring. SD-OCT showed loss of
outer plexiform, outer nuclear, external limiting mem-
brane, and inner segment/outer segment (IS/OS) layers,
and an area of thickened and hyperreflective subretinal
scar tissue (Fig. 3c). FAF displayed lack of fluorescence
centrally, indicating RPE destruction and confirming the
presence of scar tissue (Fig. 3b). Not including the ring
of hypofluorescent peripapillary atrophy, the scar is one
disk diameter, which is twice the initial infiltrate. Thus,
our imaging demonstrates centrifugal scar expansion
and photoreceptor loss as the primary causes for vision
loss. In other reports, vision loss occurred in the pres-
ence of macular edema [12,13], a clinical finding absent
in this case.
Our patient remains at risk for further vision loss from
potential CNV. FAF and SD-OCT imaging (Fig. 3) showed
inflammatory and infectious destruction of Bruch’s mem-
brane and RPE destruction, creating a locus for potential
development of CNV. We suspect that once the integrity
of the RPE layer has been violated, there is endophytic
spread of the infection into the retina and vitreous, which
increases the risk of further visual loss and the chance of
requiring surgery. We emphasize that both SD-OCT and
FAF highlight findings that were only previously demon-
strable on histopathology. More importantly, they serve as
non-invasive and readily available tools for monitoring
progression and for informing the clinician regarding the
effectiveness of various treatment modalities and progno-
sis for visual recovery.
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